Request Discount Coupon

View Synopsis & Table of Content
{reportSlug=global-cd-antigen-cancer-therapy-market, reportId=12719, mktKeyword=CD Antigen Cancer Therapy, cagr=0.00, publishDate=Mar 2022, priceOption2=6800, reportTitle=CD Antigen Cancer Therapy Comprehensive Study by Type (Monoclonal Antibodies, Antibody-Drug-Conjugates, Tri-Functional & Bi-Specific T-Cell Engager Antibodies, Other), Application (Hospitals, Homecare, Specialty Clinics, Others), Drugs Type (Rituximab, Ocrelizumab, Ofatumumab, Obinutuzumab, Others), Sales Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), CD Antigens (CD19, CD20, CD22, CD30, CD33, CD37, CD38, CD70, CD137), Administration Route (Intravenous, Subcutaneous, Others) Players and Region - Global Market Outlook to 2027, baseYr=2021, totalTableFig=212, priceOption1=3750, forecastYr=2027, noOfPages=236, reportKey=12655, breadcrum=Global CD Antigen Cancer Therapy Market}
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Select User Access Type

Key Highlights of Report


Mar 2022 236 Pages 97 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Connect with Us
AMA Research Sales Support

Praveen Kumar

Head - Sales
AMA Research - Asia Pacific Client Engagement Partner

Filza Sayed

APAC Client Engagement Partner